Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-08

Clinical Trial Update: Treatment of (IDA) by (FPC) Delivered Via Infusion Pump in Patients Receiving Home Infusion Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating FPC delivered via infusion pump for treating iron deficiency anemia in home infusion therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FPC

Snippet

Sponsor: Rockwell Medical Technologies, Inc. | Conditions: Iron Deficiency Anemia | Phase 2 | Status: UNKNOWN